Current perspectives of U.S. Managed Care Organizations and Pharmacy Benefit Managers on the availability of 10 mg Lipitor OTC

  • Print
  • Connect
  • Email
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
By Brenda Runyan, Elizabeth Anne Jackson | 09 December 2015

Milliman conducted market research with pharmacy and therapeutics committee members of U.S. managed care organizations and pharmacy benefit managers to gain their perspectives on the potential availability of 10 mg Lipitor over-the-counter.

The market research reconfirmed some of the findings from a primary market research study published in the Journal of Managed Care Pharmacy in 2004, but also offers insight into previously unexamined areas. Most of the payers interviewed believe that the availability of an over-the counter statin could increase treatment rates of people with elevated LDL, which they perceive as a positive.

This report was commissioned by Pfizer, Inc.